MD Epidemiology
Depressive symptoms in the population are common, but having symptoms is not the same thing as meeting criteria for a depressive disorder. In the NMHWS, 19% of adults reported at least 2 weeks of depressed mood or loss of interest in the past year, 6.3% met the full DSM-IV criteria at some point in the previous year, but only one-half of these were cases at the time of the NMHWS. 2 Depression Is a Chronic Disorder. At the severe end of the spectrum, two 15-year prospective studies of individuals admitted to hospital with depression found these patients did not do well. 3, 4 Only a fifth of these 2 cohorts recovered and remained continuously well; three-fifths recovered but also had further episodes; a 10th were lost to suicide; and a 10th were always incapacitated by depression. A 12-year study in US specialist care, again presumably of people with more severe illnesses, showed that patients had symptoms in 60% of follow-up weeks and met full criteria for an MDE in 15% of those weeks. 5 This is one of the few studies that have documented the significance of both subthreshold and threshold depression in a cohort followed for a substantial period. Cuijpers and Smit 6 have assembled a series of studies showing that individuals with 1 to 4 symptoms have a 5-fold increase in risk of developing MD, compared with individuals with no symptoms.
Depression Remits and Recurs. The US National Comorbidity Survey showed that three-quarters of people aged 15 to 54 years who had ever met criteria for depression reported more than one episode. Their mean age was 34 years, and they reported an average of 4 MDEs in the 11 years since their first MDE. 7 The World Health Organization's Global Burden of Disease 2000 study estimated a mean MDE duration of 26 weeks 8 and the literature is consistent with this. 9 The median duration of an MDE is less, around 13 weeks. If MDEs have a mean duration of about 6 months, some episodes will last weeks, others (perhaps 5% to 10%) will not remit for some years, and variation in duration is considerable. Episodes recur, with the average number of MDEs predicted from community survey data being around 8 in an individual's lifetime, but again variation in recurrence is considerable. Thus the average individual with MD can expect to meet criteria for an MDE for 4 years in their lifetime. In addition, judging from the data on more severe cases, they will report symptoms of depression that do not meet criteria for a diagnosis but nevertheless are associated with some disability for 3 or 4 times as long, that is for 12 to 16 years in their lifetime. However, provided they do not commit suicide, they can expect 60 years in their lifetime without any depressive symptoms, including some 35 years of their working life.
Depression Occurs Throughout the Lifespan. In the US National Comorbidity Study, 17% remembered symptoms that met criteria for MD in their lifetime to date; however, their average age was only 34 years, therefore the rates were reduced because of failure to recall and because only part of the age of risk had passed. 7 A modelling study, using Australian and Dutch data, and allowing for age of respondent and recall bias, estimated the lifetime risk of at least one MDE as 30% for male respondents and 40% for female respondents. 10 On the basis of 3 prospective cohorts followed from birth to 26 years, 11 from 24 to 50 years, 12 and from 70 to 85 years 13 we have estimated that at least one-half the population will experience at least one MDE during their lifetime. 14 This explains why depression is such an important public health problem.
MD Disability and Burden
Moussavi et al 15 studied a quarter of a million respondents in 60 countries and found that MD produces a greater decrement in health than other chronic diseases such as angina, arthritis, asthma, and diabetes. 15 In addition they found that those with angina, arthritis, asthma, or diabetes also had increased risks of MD. When MD was comorbid with any of these diseases, the disability score was worse than with any other pair of these chronic physical diseases ( Table 1 ).
The first Global Burden of Disease report 16 came to a similar conclusion. Nonfatal burden for a disease was estimated from the product of prevalence multiplied by expert judgments about the average disability level. Many were surprised when MD was ranked as the leading determinant of disability in the world. 16 Subsequent burden of disease studies have confirmed this finding, both in developed countries such as Australia and in the world at large. 17, 18 Mental health surveys have previously defined the prevalence of MD in different countries; however, the disability used in the burden of disease studies has remained dependent on expert judgments, an indirect and possibly erroneous measure. The Moussavi et al study 15 is based on direct measures of disability and supports the finding that MD is associated with high levels of disability. MD is a chronic disorder that remits and recurs. Could a remitting disorder generate such disability? The point prevalence of MD is similar to the chronic physical diseases studied; however, the lifetime risk, the number of individuals who cycle in and out of depression, is 5 to 10 times greater than the lifetime risk of any of the other diseases studied. When it does occur, depression is more disabling than either of the 4 chronic physical diseases, angina, arthritis, asthma, or diabetes.
Why Does the Burden of a Disease Persist?
Why does the burden of any disease persist? The burden of any disease, we would argue, persists under numerous circumstances, including: · causes are overwhelming (for example, in epidemics); · prevention is ineffective (for example, in asthma);
· the disease is difficult to detect or diagnose (for example, in carcinoma of head of the pancreas); · the condition remits and recurs (for example, in migraine); · treatment is not effective, too expensive, unavailable, or unacceptable (for example, in chronic obstructive pulmonary disease); · individuals do not seek treatment (for example, in hypertension); · effective care is not provided.
Does this model explain why the burden of MD remains so great?
Do the Causes of Depression Overwhelm?
Probably Not. Genes and environmental stressors, and comorbidity with physical illness or owing to medications or substance abuse are the usual answers to what causes MD. If MD, worldwide, is the single largest determinant of disability it might be expected that the literature on causation would be detailed and considerable. It is not. In a review and metaanalysis, Sullivan et al 19 concluded that the point estimate of heritability of liability was 37%, probably the lowest for any of the internalizing disorders. 20 Adverse life events are one class of environmental events that precede depression; however, some of the relation is noncausal as individuals predisposed to, or with, MD put themselves into high-risk environments. 21, 22 Some adversities are associated with increased risks of MD many years later, child sexual abuse is one example. 23 The current interest is in gene and environment interactions in which adversity becomes salient in individuals with the requisite genetic vulnerability; however, these influences do not account for most MDEs. 24, 25 The problem with the adversity literature is its lack of specificity-most individuals exposed to adversity do not develop a mental disorder, let alone MD. Further caution is required given that some high-trauma countries do not have high rates of depression. 26 Demographic correlates are not helpful. In the NMHWS, MD was significantly more common (adjusted odds ratios) in women, less common in the elderly, and more common in those not married, with less education, and not in the labour force. 2 The last 3 variables are markers of deprivation; however, whether individuals are depressed because of their deprived status or have a deprived status because of recurrent depression is unclear.
If depression is a disorder, that is, a failure of adaptation that can affect one-half of the human population at some time, then it is difficult to discern a predominant cause. Nesse 27 argued that some episodes of depression might have evolutionary explanations and be adaptive. Others hope that causes (and treatments) may become clearer if we look at subtypes of depression. 28 Either way, it is difficult to see that the causes presently identified could overwhelm our ability to prevent or treat MD. 
Can Prevention Work?
Probably. We have argued that prevention of MD in young individuals is, or could be, effective. 29, 30 Cuipers et al 31 came to a similar conclusion. If the median age of onset of MD is 32 years and the 25th percentile is 18 years, then it is imperative that we deliver universal prevention programs in high schools. We are presently delivering courses 32 to help junior high school students manage stress, anxiety, and depression that fit within the demands of the high school curriculum. We have data that the course on stress management is effective and are gathering data on the effectiveness of the other 2 courses. 32
Is Depression Difficult to Detect or Diagnose?
Yes and no, but there are issues.
The Present Diagnostic Criteria Are Difficult to Remember and Could Be Shortened. One problem for a clinician is the difficulty of remembering the criteria. Humans can routinely recall no more than 5 to 9 items from a list. Zimmerman et al 33 reviewed evidence that the 9 symptoms in Criterion A in MD were poorly recalled. Depression is a common disease that all physicians should be able to screen for. It is difficult to screen a patient if you cannot remember the criteria ( Table 2) .
If it were possible to simplify the diagnostic criteria without loss of validity the traditional clinical interview may become more reliable. Zimmerman et al 33 concentrated on the 5 psychological symptoms contributing to Criterion A (depression, poor interest, worthlessness, poor concentration, and thoughts of death) and found that almost all patients who had met criteria for 5 or more of the 9 traditional symptoms met this new criteria for 3 of the 5 psychological symptoms. We confirmed his finding; 3/5 symptoms produced 97% agreement with the usual 5/9 criterion. 34 That one criterion could be simplified without loss of validity is understandable; however, could the 20 pieces of information and 5 criteria that form the diagnosis be simplified? In MD, 6 pieces of information from the NMHWS (5 symptoms of Criterion A combined with no history of mania and [or] hypomania) identified most of the same individuals as had the full criteria that required 20 pieces of information.
Depression and Anxiety Disorders Are Internalizing Disorders. Are the individual depressive and anxiety disorders distinct? If this were the case then the rates of cooccurrence among these disorders would occur at chance levels. However, the rates of cooccurrence among these mental disorders are considerably higher than would be expected. 35, 36 It was suggested that such rates could reflect the existence of higher-order dimensions of psychopathology. Numerous studies have examined this and found similar groupings of mental disorders. Slade and Watson 37 identified a hierarchical 3-factor structure as the best fit to 10 common DSM-IV and 11 common ICD-10 mental disorders. This structure was characterized by correlated distress and fear factors (which were best considered lower-order facets of a broader internalizing factor) as well as an externalizing factor. As can be seen in Figure 1 , the individual mental disorders that were characteristic of the distress factor were MD, dysthymia, generalized anxiety disorder, posttraumatic stress disorder, and neurasthenia (the latter in the ICD-10 model; in DSM-IV, neurasthenia would be coded as undifferentiated somatoform disorder 300.81). The mental disorders that were characteristic of the fear factor were social phobia, agoraphobia, panic disorder, and obsessive-compulsive disorder. In this study, the externalizing factor was best characterized by drug and alcohol dependence (Figure 1 ).
Depression Is a Dimension Not a Category.
A diagnosis of MD is currently made when there are 5 or more of the 9 symptoms specified in Criterion A. Is there evidence of a natural break in the distribution of symptoms at or around this threshold? Numerous large studies have found that the relation between the number of symptoms and measures of impairment was linear, with no evidence of any natural discontinuity that would support the use of 5/9 symptoms as a critical diagnostic threshold. 7, 38, 39 One of the implications is that the decision to treat can be made at any level on the continuum. 40 The frequent use of Depressive Disorder Not Otherwise Specified 41 makes it clear that clinicians often ignore the DSM-IV threshold that requires so many pieces of information. One of the reasons that the burden persists may be that our medical model of a treatment threshold obscures the need for stepped care to match treatment intensity to case severity.
Routine Screening. One response to the dimensional nature of MD is to routinely use a short screening scale. In our clinic, we have every patient complete the 9-item PHQ-9 at the registration desk each time they attend. The score is entered on the record by the receptionist. The PHQ-9 is a self-report instrument that parallels the symptom criteria for depressive disorders listed in DSM-IV. Depression severity is judged from the total score. 42 Because of its brevity and sensitivity to change over time, the PHQ-9 can be used for screening new patients for depression as well as for routine evaluation of outcome and response to treatment. There are longer and more detailed scales available; however, the PHQ-9 is recommended as simple, acceptable to patients, and practical for clinicians to use. It is brief, reliable, and valid. 43 Depressed Patients May Not Complain. At the 15-year follow-up of a cohort of patients with MD, we discovered that only one-fifth of the patients had remained continuously well after discharge from hospital. 3 Few of the four-fifths who relapsed returned for treatment or sought other treatment. Depression seemed to rob individuals of their motivation to be well, despite the disability. In a similar vein, depressed patients in primary care with a normalizing attributional style were very unlikely to be detected unless one relied on a structured questionnaire; they accepted their depressed state but did not complain. 44 In a seminal primary care study, Kirmayer et al 45 noted that three-quarters of individuals with MD presented with somatic complaints, and that such presentations more than halved the rate at which clinicians recognized depression. MD may not be simple to diagnose unless the doctor asks or the clinic routinely uses a screening scale.
Depression That Remits and Recurs Leads to Treatment Difficulties
Yes, this is a problem. All chronic diseases wax and wane but depression can disappear completely for years and then return. Does this affect efforts to reduce the burden? If the median duration of an episode is 13 weeks, then by the time the average individual has thought of getting treatment, remission might have begun. In the NMHWS 65% of individuals with depression at the time of interview reported at least one mental health consultation in the past year, and 50% reported potentially effective treatment with medication or CBT. An equal number of individuals had met criteria during the year but had remitted by the time of interview. They reported similar rates (59%) of one or more mental health consultations but only 36% reported getting medication or CBT, as though the beginning of recovery from this episode reduced the need for effective treatment to be initiated; whereas, if this was not the first episode, treatment should have been maintained for at least 2 years.
Response to treatment is greeted with relief by patient and doctor, although the recovery may be due to natural remission and quite independent of treatment. Few clinicians are comfortable talking to patients about the prospect of relapse and the need for continuing treatment. When we argued that depression should be treated as a chronic disease, even in remission, numerous doctors wrote to say that they were relieved that they could stress the need for ongoing treatment and broach the possibility of relapse. 9 Active treatment should be continued for 2 years in individuals with a history of recurrent depression, and patients should learn to recognize the early warning signs of relapse.
Treatment for Depression Is Difficult, Ineffective, Expensive, and Unavailable
No, treatment is none of these things. There are many sensible guidelines for practice. 46,47 Antidepressant medication is widely prescribed, moderately effective, cost-effective, associated with reductions in suicide, and increasingly acceptable to the public. The evidence supporting CBT is similarly robust, although estimating rates of adequate CBT are much harder to measure than prescription rates. We paraphrase the simplest level in the NICE guidelines 46 : For mild depression, provide advice about sleep hygiene, exercise, and problem solving plus self-help material, often in the form of computerized CBT, followed by review within 2 weeks. Antidepressants are not recommended, as the risk and benefit ratio does not justify such treatments. In moderate depression, antidepressants are strongly recommended, coupled with CBT, either face to face or via computer, problem solving, and behavioural activation. Fluoxetine or citalopram were favoured over all other antidepressants on the grounds of costs and safety. If one of these drugs does not work then transfer to the other would be indicated before referral for advice about use of the remaining antidepressants. 48 Treatment of severe depression is essentially the same 49 plus referral for specialist advice, including advice about the value of electro-convulsive therapy. Therefore, the issue is not what to do once the depression is recognized-there is already persuasive evidence that different treatments are appropriate for different degrees of depression severity-the issues are recognition and prudent continuing management of this chronic disease. When MD is comorbid with physical disorders, the indicated treatments are a little different: treatment depends on the severity of depression, and caution regarding interactions between medications is necessary, and proactive care essential.
Individuals With Depression Do Not Come for Treatment
This is only partly true. In the NMHWS, just less than one-half of the individuals who met criteria for MD during the year reported no mental health consultation. One-third of those saw no need for treatment, saying, "I prefer to manage myself"; however, two-thirds saw a need for treatment and most thought that information, counselling, or practical help would meet their needs but had not asked. However, only 1 in 6 individuals who had not consulted thought that medication or CBT would be appropriate. Patient education as to the therapies that are likely to benefit is clearly an issue in most individuals who do not seek treatment. Fortunately this appears to be changing. 50
The Organization of Care Itself Contributes to the Continued Burden
Could we provide more effective care? A demand-driven model of practice in which patients seek help only when they deem it necessary can never be appropriate for an episodic, but lifelong, condition that affects hope and volition, reduces compliance, and predisposes to suicide. When patients relapse they often perceive that they have failed their clinicians and their families and, therefore, decide to suffer in silence. We should discuss with them the chronic nature of their disorder and steps needed to manage it, exactly as we would discuss these issues with an individual with diabetes or asthma. 9 Participatory self-management, predicated on a written action plan, is the hallmark of self-management programs that reduce morbidity. In asthma training programs this improvement in outcome began to be measurable because patients started to measure themselves. Patients using the PHQ-9 can do likewise. · Computer support-use programs that record treatment and outcomes of all patients, and flag when progress is not as expected.
Proactive care, in accord with the Wagner criteria, produced better outcomes in the first year. Continued enhanced care is required; however, as individuals with MD generate twice the health care costs of other primary care attenders and while proactive care costs more than usual care, the cost per successfully treated patient is lower and the cost-effectiveness is higher, compared with patients receiving usual care.
Whitty and Gilbody 53 reviewed the United Kingdom's NICE guidelines and called for investment in case management and related organizational changes in primary care. They later reviewed the incremental cost-effectiveness of these case management and collaborative care enhancements, reporting, on the basis of 11 studies of 4600 patients, that the incremental cost-effectiveness ratios of enhanced primary care treatment was $13 to $25 per depression-free day. 54 If this means increased work force productivity then such strategies are indeed cost-effective. In a subsequent metaanalysis, they found that depression outcomes from collaborative care remained improved at 6 months and at 5 years. They related the improved effectiveness to supervision by experienced case managers that lead, among other changes, to improved medication compliance. 55 We might expect that the United Kingdom's National Health Service could implement the collaborative care that seems so effective in reducing the burden of depression; however, Whitty and Gilbody 53 doubted whether the required changes would be implemented. In the United States, some health care systems have been able to implement such programs; however, how widespread these programs are is uncertain. 56 Private practice fee-for-service models, whether insurancebased or not, do not encourage proactive collaborative care. Australia is edging toward subsidizing the work of practice nurses for specific tasks (for example, spirometry); however, despite the expansion of access of allied health staff and nurses to fee for service insurance payments, there is no provision for proactive collaborative care in the longer term. The problem is that the health system is still predicated on the acute care model-get sick, go to doctor, get treatment, become well-that is totally inappropriate in an environment in which the management of chronic diseases such as depression is a dominant activity. If we want to reduce the burden of depression we will need to change the way we treat individuals with depression, not necessarily change the treatments we use, but change the way we organize their treatment.
